加拿大投2380万加元扩建魁北克放射性药物厂 创造与保留225个岗位
加拿大魁北克省柯克兰10月8日消息，加拿大工业部长 Mélanie Joly 当天宣布，联邦政府通过战略应对基金向 Jubilant Radiopharma 公司投资2380万加元，支持其在柯克兰的放射性药物工厂现代化与扩建项目，项目总投资9450万加元。
扩建后，该厂将成为放射性药物生产与研发的全球卓越中心。这类药物用于癌症等疾病的诊断成像与治疗，供应链高度依赖短半衰期的同位素生产能力，本土产能对加拿大医疗系统有直接意义。
项目将创造与保留225个就业岗位，并提供35个学生带薪实习名额。Jubilant Radiopharma 是印度 Jubilant Pharmova 集团旗下企业，其柯克兰厂是该集团在北美的重要生产基地。
加拿大创新、科学和经济发展部表示，自2020年以来，加拿大已在43个生物制造、疫苗与治疗药物项目上投入超过25亿加元，此次投资延续这一布局。
Canada Invests $23.8 Million in Quebec Radiopharmaceutical Plant, Supporting 225 Jobs
In Kirkland, Quebec, Canada, Industry Minister Mélanie Joly announced on October 8 a $23.8-million federal investment from the Strategic Response Fund in Jubilant Radiopharma Inc., supporting the modernization and expansion of its Kirkland radiopharmaceutical plant. The total project is valued at $94.5 million.
Once expanded, the facility will serve as a global centre of excellence for radiopharmaceutical production and research. These medicines are used in diagnostic imaging and treatment for diseases such as cancer, and their supply depends on short-lived isotope production, making domestic capacity directly relevant to Canada's health system.
The project will create and maintain 225 jobs and provide 35 paid student co-op placements. Jubilant Radiopharma is part of India's Jubilant Pharmova group, and the Kirkland plant is a key North American production site for the group.
Innovation, Science and Economic Development Canada says Ottawa has invested more than $2.5 billion since 2020 across 43 biomanufacturing, vaccine and therapeutics projects, and this investment continues that build-out.
来源：加拿大创新、科学和经济发展部
发布：GSM·美国（发布链接）
图片来源：正电子发射断层扫描（PET）设备，放射性药物用于此类诊断成像。/ A PET scanner; radiopharmaceuticals are used in this kind of diagnostic imaging. (Photo: Agentschap Zorg en Gezondheid, CC BY 3.0, via Wikimedia Commons)
GSM Global · 本篇英文版 English edition of this story
